My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 147

    1.

    Skin autofluorescence is a strong predictor of cardiac mortality in diabetes.

    Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO, Smit AJ.

    Diabetes Care. 2007 Jan;30(1):107-12.PMID: 17192342 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.

    Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ.

    J Am Soc Nephrol. 2005 Dec;16(12):3687-93. Epub 2005 Nov 9.PMID: 16280473 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications.

    Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ, Gans RO, Bilo HJ.

    Diabetes Care. 2008 Mar;31(3):517-21. Epub 2007 Nov 26.PMID: 18039805 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Simple non-invasive assessment of advanced glycation endproduct accumulation.

    Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ.

    Diabetologia. 2004 Jul;47(7):1324-30. Epub 2004 Jul 9.PMID: 15243705 [PubMed - indexed for MEDLINE]Related articles

    5.

    Simple noninvasive measurement of skin autofluorescence.

    Meerwaldt R, Links T, Graaff R, Thorpe SR, Baynes JW, Hartog J, Gans R, Smit A.

    Ann N Y Acad Sci. 2005 Jun;1043:290-8.PMID: 16037251 [PubMed - indexed for MEDLINE]Related articles

    6.

    Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes.

    Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, Smit AJ.

    Diabetes Care. 2006 Dec;29(12):2654-9.PMID: 17130200 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy.

    Sato E, Mori F, Igarashi S, Abiko T, Takeda M, Ishiko S, Yoshida A.

    Diabetes Care. 2001 Mar;24(3):479-82.PMID: 11289471 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations.

    Mulder DJ, Water TV, Lutgers HL, Graaff R, Gans RO, Zijlstra F, Smit AJ.

    Diabetes Technol Ther. 2006 Oct;8(5):523-35. Review.PMID: 17037967 [PubMed - indexed for MEDLINE]Related articles

    9.

    Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.

    Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, Bilo HJ, Smit AJ.

    Diabetologia. 2009 May;52(5):789-97. Epub 2009 Mar 10.PMID: 19274450 [PubMed - indexed for MEDLINE]Related articles

    10.

    Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.

    Galler A, Müller G, Schinzel R, Kratzsch J, Kiess W, Münch G.

    Diabetes Care. 2003 Sep;26(9):2609-15.PMID: 12941727 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.

    Hartog JW, Hummel YM, Voors AA, Schalkwijk CG, Miyata T, Huisman RM, Smit AJ, Van Veldhuisen DJ.

    J Card Fail. 2008 Sep;14(7):596-602. Epub 2008 May 27.PMID: 18722326 [PubMed - indexed for MEDLINE]Related articles

    12.

    Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy.

    Meerwaldt R, Links TP, Graaff R, Hoogenberg K, Lefrandt JD, Baynes JW, Gans RO, Smit AJ.

    Diabetologia. 2005 Aug;48(8):1637-44. Epub 2005 Jul 14.PMID: 16021416 [PubMed - indexed for MEDLINE]Related articles

    13.

    Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.

    Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Nakatani Y, Ohtoshi K, Hayaishi-Okano R, Kosugi K, Hori M, Yamasaki Y.

    Diabetes Care. 2005 Nov;28(11):2716-21.PMID: 16249545 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Relationship between autofluorescence and advanced glycation end products in diabetic lenses.

    Abiko T, Abiko A, Ishiko S, Takeda M, Horiuchi S, Yoshida A.

    Exp Eye Res. 1999 Mar;68(3):361-6.PMID: 10079144 [PubMed - indexed for MEDLINE]Related articles

    15.

    Skin autofluorescence in type 2 diabetes: beyond blood glucose.

    Monami M, Lamanna C, Gori F, Bartalucci F, Marchionni N, Mannucci E.

    Diabetes Res Clin Pract. 2008 Jan;79(1):56-60. Epub 2007 Aug 20.PMID: 17707942 [PubMed - indexed for MEDLINE]Related articles

    16.

    Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients.

    Hartog JW, de Vries AP, Bakker SJ, Graaff R, van Son WJ, van der Heide JJ, Gans RO, Wolffenbuttel BH, de Jong PE, Smit AJ.

    Nephrol Dial Transplant. 2006 Aug;21(8):2263-9. Epub 2006 Apr 5.PMID: 16597636 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease.

    Hartog JW, de Vries AP, Lutgers HL, Meerwaldt R, Huisman RM, van Son WJ, de Jong PE, Smit AJ.

    Ann N Y Acad Sci. 2005 Jun;1043:299-307.PMID: 16037252 [PubMed - indexed for MEDLINE]Related articles

    18.

    Ankle brachial pressure index usefulness as predictor factor for coronary heart disease in diabetic patients.

    Filippella M, Lillaz E, Ciccarelli A, Giardina S, Massimetti E, Navaretta F, Antico A, Veronesi M, Lombardi G, Colao A, Ghigo E, Benso A, Doveri G.

    J Endocrinol Invest. 2007 Oct;30(9):721-5.PMID: 17993762 [PubMed - indexed for MEDLINE]Related articles

    19.

    Increased collagen-linked fluorescence in skin of young patients with type I diabetes mellitus.

    Dominiczak MH, Bell J, Cox NH, McCruden DC, Jones SK, Finlay AY, Percy-Robb IW, Frier BM.

    Diabetes Care. 1990 May;13(5):468-72.PMID: 2351024 [PubMed - indexed for MEDLINE]Related articles

    20.

    Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects.

    Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

    Diabetes Care. 2008 Apr;31(4):714-9. Epub 2007 Dec 14.PMID: 18083789 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity